Author:
Pal Sumanta,Gong Jun,Mhatre Shivani K.,Lin Shih-Wen,Surinach Andy,Ogale Sarika,Vohra Rini,Wallen Herschel,George Daniel
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics,Oncology
Reference44 articles.
1. National Cancer Institute. SEER Cancer Stat Facts: Kidney and Renal Pelvis Cancer.
https://seer.cancer.gov/statfacts/html/kidrp.html
. Accessed 3 Feb 2019.
2. Ljungberg B, Campbell SC, Choi HY, et al. The epidemiology of renal cell carcinoma. Eur Urol. 2011;60(4):615–21.
3. Gupta K, Miller JD, Li JZ, Russell MW, Charbonneau C. Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): a literature review. Cancer Treat Rev. 2008;34(3):193–205.
4. Pal SK, Ghate SR, Li N, et al. Real-world survival outcomes and prognostic factors among patients receiving first targeted therapy for advanced renal cell carcinoma: a SEER-Medicare database analysis. Clin Genitourin Cancer. 2017;15(4):e573–82.
5. American Cancer Society. Survival rates for kidney cancer by stage.
https://www.cancer.org/cancer/kidney-cancer/detection-diagnosis-staging/survival-rates.html
. Accessed 3 Feb 2019.
Cited by
36 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献